Cervical Cancer Patient Engagement Toolkit Now Available
ORWH is a partner of the Federal Cervical Cancer Collaborative (FCCC) led by the Health Resources and Services Administration. FCCC has recently released Improving Patient Engagement in Cervical Cancer Prevention: Communication Toolkit to Build Provider Capacity, which aims to support people who work at health centers and in safety-net settings.
ORWH is Advancing the Representation of Women in Science Careers
Under the leadership of Xenia Tigno, Ph.D., Associate Director for Careers, ORWH has launched a variety of funding opportunities that seek to address the points in a scientist’s career that Dr. Tigno refers to as “precipices where women usually fall off.”
New Issue of In Focus Explores Technology and Innovation in Women's Health Research
NIH’s major investments over the past decades have spurred advancements for in vitro bioengineering tools that enable the use of human cells and tissues for preclinical testing. These advances have the potential to expedite the development, testing, and clinical use of novel therapeutics. In Focus 7.4 describes how the tools' advancements are accelerating research on several conditions that solely or predominantly affect women.
The awards of $3,000 each will help defray the cost of attending the Organization for the Study of Sex Differences Annual Meeting taking place June 1–5, 2025, in Albuquerque, New Mexico.
Implementation Research for Multi-morbidity Management in the Context of Non-communicable Diseases in Low- and Middle-Income Countries and US Tribal Populations (PAR-25-213), (PAR-25-223) First available due date: January 7, 2025
NOSI: Research on the Health of Women of Underrepresented, Underserved, and Underreported (U3) Populations (Admin Supp Clinical Trial Optional) (NOT-OD-24-179) First available due date: January 22, 2025
Research to Address Systemic and Structural Barriers and Facilitators to Improve the HIV Pre-Exposure Prophylaxis (PrEP) Care Continuum for People Who Use Substances (R01/R34 Clinical Trials Required) (RFA-DA-26-003), (RFA-DA-26-004) Earliest submission date: February 12, 2025
Notice of ORWH participation in NLM Grants for Scholarly Works in Biomedicine and Health (G13 Clinical Trial Not Allowed) (PAR-23-183) Application due date: February 26, 2025
Enhancing Mechanistic Research on Precision Probiotic Therapies (R61/R33 Clinical Trial Optional) (PAR-24-238), (PAR-24-239) First available due date: June 2, 2025
NOSI: Support for Conferences and Scientific Meetings to Support Consensus Building for Autoimmune Disease Research Related Common Data Elements (NOT-OD-24-145) Submission dates follow the NIH standard due dates Expiration date: December 14, 2026 Find out more information about how to apply in this video and by referencing the presentation slides.
NOSI: Research Opportunities Centering the Health of Women Across the HIV Research Continuum (NOT-OD-24-119) Submission dates vary by awarding NIH Institute or Center Contacts
Notice of NIGMS Interest in Research to Address Biological Sex Differences (NOT-GM-25-003) Please direct all inquiries to a relevant NIGMS Program Officer
